PharmaEssentia
@PharmaEssentia
Followers
584
Following
22
Statuses
296
Official Twitter for PharmaEssentia. Reshaping treatment paths for diseases with significant unmet medical needs. Community guidelines: https://t.co/fOZMWXpfl2
Burlington, MA
Joined January 2016
On this #WomenInScience Day, we celebrate all the brilliant women advancing science—especially the incredible women of PharmaEssentia. Your passion drives innovation and inspires us every day.
0
0
0
FiercePharma’s Zoey Becker recently highlighted the promising topline results from our Phase 3 SURPASS-ET trial, exploring a potential new treatment for patients with essential thrombocythemia.
0
0
0
On #WorldCancerDay, we stand with researchers, healthcare professionals, and patients to discover new, innovative ways to fight cancer and create a healthier future.
0
0
0
A very Happy #LunarNewYear from PharmaEssentia! As a Taiwanese-based company, we celebrate the Year of the Snake, which symbolizes wisdom, elegance, and transformation. We hope the new year brings good wishes to all the communities we serve.
0
0
0
We had a great time at last week’s #JPM2025 meeting—reconnecting with colleagues, forging new relationships, and sharing more about our latest accomplishments and upcoming milestones! Access the recording and slides here:
0
1
1
Today, join us in honoring Dr. Martin Luther King Jr.’s life, legacy, and civil rights activism. #MLKDay2025
0
0
0
Work with us to defy expectations in #CancerTreatment. Together, we can be essential! Learn more:
0
0
0
Do you know what usually causes #PolycythemiaVera (PV)? Know the facts about PV and learn more about our focus on providing new therapeutic solutions for patients with #MPNs:
0
0
0
We’re excited to share that our Phase 3 SURPASS-ET trial of ropeginterferon alfa-2b-njft (P1101) met its primary endpoint, showing durable responses in essential thrombocythemia (ET) patients. We look forward to sharing more details in the near future.
0
1
4
Happy New Year! In 2025, we look forward to continuing our work on solutions that put patients first and with the goal of improving the lives of everyone living with #MPNs.
0
0
0
Know the facts about polycythemia vera (PV) and learn more about our focus on providing potential therapeutic options for patients with #MPNs:
0
1
1
Happy Holidays from PharmaEssentia! We hope you enjoy this time with friends, family, and loved ones.
0
0
0
We’re excited to share that we will be presenting at #JPM2025 on Thursday, Jan 16th at 1:45PM PT. A live webcast of the presentation will be available on our website, and replays will be archived for at least 30 days: Read more:
0
0
1
Know the facts about polycythemia vera (PV). PV is a chronic blood cancer that affects approximately 160,000 people in the U.S. Learn more about our focus on providing potential therapeutic solutions for patients with #MPNs:
0
2
4
The PharmaEssentia team was proud to support @ASH_hematology Foundation’s Annual Run/Walk at #ASH24! Thanks to the team who showed up bright and early in support of #hematology research.
0
0
2
In his new role, Joe will lead global resource allocation to align commercial strategies and drive performance, ensuring the highest level of performance across our global operations.
0
0
0
Wishing our community and colleagues a Happy Thanksgiving! We hope you enjoy this time with your loved ones.
0
0
1
Today, we announced that nine new abstracts will be presented during the 66th @ASH_hematology Annual Meeting and Exposition in San Diego, CA. Learn more: #ASH24 #MPNs
0
1
1
With a focus on improving the lives of those impacted by this rare condition, we are continuously evolving our approach to treatment under the leadership of Dr. Ko-Chung Lin. Read more about our story:
0
0
0